Novavax's (NVAX) CEO Stan Erck on Q4 2016 Results - Earnings Call Transcript

2/28/17

Novavax, Inc. (NASDAQ:NVAX)

Q4 2016 Results Earnings Conference Call

February 27, 2017 04:00 PM ET

Executives

Andrea Flynn - Associate Director, IR

Stan Erck - President and CEO

Dr. Greg Glenn - President of Research and Development

Buck Phillips - CFO

Analysts

Jessica Fye - J.P. Morgan

Joel Beatty - Citi

Edward Tenthoff - Piper Jaffray

Kevin DeGeeter - Ladenburg

Operator

Good day, ladies and gentlemen and welcome to the Novavax Fourth Quarter and Full Year 2016 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a Q&A session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the conference over to Ms. Andrea Flynn, Associate Director, Investor Relations. You may begin.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect